Cravath, Weil Advise J&J On $480M Micrus Purchase
Johnson & Johnson said Monday it was expanding its line of stroke treatment products with the $480 million cash-for-stock acquisition of medical device maker Micrus Endovascualar Corp....To view the full article, register now.
Already a subscriber? Click here to view full article